{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:25:57Z","timestamp":1788852357407,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ijpharm.2017.09.070","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T08:45:49Z","timestamp":1506674749000},"page":"198-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Eyelid skin as a potential site for drug delivery to conjunctiva and ocular tissues"],"prefix":"10.1016","volume":"533","author":[{"given":"Gerard Lee","family":"See","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Sagesaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Sugasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Todo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sugibayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.09.070_bib0005","first-page":"163","article-title":"Skin models for testing of transdermal drugs","volume":"8","author":"Abd","year":"2016","journal-title":"Clin. Pharmacol. Adv. App."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.colsurfb.2016.08.048","article-title":"Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: formulation development, in-vitro and in-vivo studies","volume":"148","author":"Akhter","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0015","series-title":"Skin Anatomy","author":"Amirlak","year":"2015"},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/861904","article-title":"Ophthalmic drug dosage forms: characterisation and research methods","author":"Baranowski","year":"2014","journal-title":"The Sci. World J."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.addr.2012.05.001","article-title":"Recent advances in predicting skin permeability of hydrophilic solutes","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1440-1681.2000.03288.x","article-title":"Biopharmaceutical considerations in topical ocular drug delivery","volume":"27","author":"Davies","year":"2000","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0035","series-title":"Gibaldi\u2019s Drug Delivery Systems in Pharmaceutical Care","author":"Desai","year":"2007"},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1194\/jlr.R800039-JLR200","article-title":"The outer frontier: the importance of lipid metabolism in the skin","volume":"50","author":"Feingold","year":"2009","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.06.015","article-title":"Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability","volume":"396","author":"Gan","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS. J."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cis.2015.08.002","article-title":"Mechanistic modelling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses","volume":"233","author":"Gause","year":"2016","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0060","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1248\/bpb.30.2135","article-title":"Analysis of skin disposition of flurbiprofen after topical application using dual agar gel discs-inserted rats","volume":"30","author":"Hasegawa","year":"2007","journal-title":"Biol. Phar. Bull."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1248\/bpb.26.69","article-title":"Drug delivery to the eye with a transdermal therapeutic system","volume":"26","author":"Isowaki","year":"2003","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0070","series-title":"2014. Topical Drug Bioavailability, Bioequivalence, and Penetration","first-page":"21","article-title":"Animal models for percutaneous absorption","author":"Jung","year":"2014"},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0075","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1248\/cpb.55.1002","article-title":"Development of a stick-type transdermal eyelid delivery system of ketotifen fumarate for ophthalmic diseases","volume":"55","author":"Kimura","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0080","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1080\/03639045.2016.1185437","article-title":"Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole","volume":"42","author":"Kumar","year":"2016","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2008.07.017","article-title":"A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers","volume":"363","author":"Li","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0090","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bjo.87.4.436","article-title":"A comparative bioavailability study of three conventional eye drops versus a single lyophilisate","volume":"87","author":"Lux","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0095","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/jps.2600620913","article-title":"Quantitative effect of topically applied anti-inflammatory agents on external ocular inflammation in rats","volume":"62","author":"Maistrello","year":"1973","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0100","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.2042-7158.1992.tb05484.x","article-title":"Prediction of skin permeability of drugs: comparison of human and hairless rat skin","volume":"44","author":"Morimoto","year":"1992","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4161\/derm.1.2.7811","article-title":"Epidermal surface lipids","volume":"1","author":"Pappas","year":"2009","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4155\/tde.10.16","article-title":"Challenges and opportunities in dermal\/transdermal delivery","volume":"1","author":"Paudel","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1023\/A:1015810312465","article-title":"Predicting skin permeability","volume":"9","author":"Potts","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0846.2007.00183.x","article-title":"Functional analyses of the eyelid skin constituting the most soft and smooth area on the face: contribution of its remarkably large superficial corneocytes to effective water-holding capacity of the stratum corneum","volume":"13","author":"Pratchyapruit","year":"2007","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0125","first-page":"656","article-title":"Modified Nile red staining method for improved visualization of neutral lipid depositions in stratum corneum","volume":"102","author":"Sheu","year":"2003","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0168-3659(99)00038-3","article-title":"Analysis of skin disposition of flurbiprofen after topical application in hairless rats","volume":"62","author":"Sugibayashi","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11095-009-9987-y","article-title":"Mathematical model to predict skin concentration of drugs: toward utilization of silicone membrane to predict skin concentration of drugs as an animal testing alternative","volume":"27","author":"Sugibayashi","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2010.10.020","article-title":"Protective effect of coenzyme Q10 against oxidative damage in human lens epithelial cells by novel ocular drug carriers","volume":"403","author":"Wang","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0145","first-page":"1","article-title":"Utility of three-dimensional cultured human skin model as a tool to evaluate skin permeation of drugs","volume":"8","author":"Watanabe","year":"2011","journal-title":"Altern. Anim. Test Exp."},{"key":"10.1016\/j.ijpharm.2017.09.070_bib0150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s004030050453","article-title":"Number of cell layers of the stratum corneum in normal skin \u2212 relationship to the anatomical location on the body, age, sex and physical parameters","volume":"291","author":"Ya-Xian","year":"1999","journal-title":"Arch. Dermatol. Res."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317309365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317309365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T21:59:15Z","timestamp":1537999155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317309365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0378517317309365"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.070","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eyelid skin as a potential site for drug delivery to conjunctiva and ocular tissues","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}